Of these genes, BCL2, PRKCA (PKC) and CDKN1A (p21) were directly associated with EGFR-TKI resistance pathway (hsa01521) and NSCLC pathway (hsa05223). This evidence concerns the gene EGFR and non-small cell lung carcinoma.